Article info
Clinical science
Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
- Correspondence to Dr Taiichi Hikichi, Hikichi Eye Clinic, Kita-sky Build, Sapporo 060-0807, Japan; thikichi{at}hikichi-eye.jp
Citation
Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
Publication history
- Received March 9, 2017
- Revised April 20, 2017
- Accepted April 23, 2017
- First published May 25, 2017.
Online issue publication
August 03, 2018
Article Versions
- Previous version (15 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.